Study for children with strep throat using beta-lactam antibiotics
Part of Infections clinical trials.
This study looks at children ages 5–15 who test positive for Group A strep (often called strep throat). It may help by testing an antibiotic approach with beta-lactam medicines for children who are expected to need treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 5 to 15 years old
- Have a rapid test that is positive for Group A strep
- Have a parent or legal guardian who can give consent
- Your clinician plans to treat you with a beta-lactam antibiotic
- Be able to take beta-lactam antibiotics safely
- Have no other bacterial infection at the same time (like pneumonia)
- Speak English (or be able to complete the study in English)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new antibody treatment can safely stop strep throat infections. Healthy adults aged 18-40 will receive the antibody and then be exposed to the strep bacteria in a controlled setting to see if it protects them.
This study compares a short course (5 days) of amoxicillin to the standard 10-day course for treating strep throat in children. The goal is to see if shorter treatment works just as well and reduces side effects.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
This study looks at bacteria (especially pneumococcus) in the nose and throat of children. It includes children with ear infections or healthy children, to understand which germs are carried and how they relate to illness.
This study is a registry that collects information about the health and outcomes of babies and children who had a serious Group B Strep infection around birth. It aims to better understand the long-term effects and improve care for families impacted by this infection.
This trial looks at whether phenoxymethylpenicillin (an antibiotic) helps people with a certain type of sore throat more than not using antibiotics. You may qualify if your symptoms match a likely bacterial cause and a rapid test for strep is negative.
Hear when a new Streptococcal Pharyngitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.